Oncology & Cancer

Breast cancer patients could benefit from controversial hormone

An international team of researchers involving the University of Adelaide is tackling the controversy over what some scientists consider to be a "harmful" hormone, arguing that it could be a game changer in the fight against ...

Obstetrics & gynaecology

'Science' features advances in preterm birth

The Aug. 15 edition of the journal Science features a major article about the most important problem in obstetrics: preterm labor. The article, "Preterm labor: one syndrome, many causes," delivers a powerful message: preterm ...

Oncology & Cancer

Understanding culprits behind fibroid tumors

(Medical Xpress)—Tremendous progress has been made in understanding how uterine fibroid tumors—the most common tumor in women – start and grow. A new paper in the New England Journal of Medicine synthesizes the latest ...

Oncology & Cancer

Breakthrough study of hormone 'cross-talk' in breast cancer

Scientists led by EPFL have successfully engrafted breast cancer cells on mice, allowing them to study in vivo the cross-talk between the estrogen and progesterone receptors that hampers hormone therapies. Their findings ...

Oncology & Cancer

Study role testosterone may play in triple negative breast cancer

Could blocking a testosterone receptor lead to a new way to treat an aggressive form of breast cancer? That's a question researchers at Mayo Clinic in Arizona and the Translational Genomics Research Institute (TGen) are exploring. ...

page 2 from 19